Quest Diagnostics has outperformed the broader market over the past year, and analysts are moderately optimistic about the ...

On Friday, Quest DiagnosticsDGX got a positive adjustment to its Relative Strength (RS) Rating, from 70 to 75. Please watch ...

A month has gone by since the last earnings report for Quest Diagnostics (DGX). Shares have added about 2.6% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the ...

This week, I will share some tips for establishing milestone goals that make sense and continue to inspire action. Plus, I'll ...

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.

Quest Diagnostics' fair value estimate remains steady at $197.25 per share, with only a slight uptick in the discount rate. This reflects minimal change in the firm's valuation assessment. While the ...

The company confirmed it will discontinue onsite laboratory testing services effective Jan. 1, but will continue providing ...

SECAUCUS, N.J., Nov. 11, 2025 /PRNewswire/ -- (NYSE: DGX), a leader in diagnostic information services, today announced that ...

新泽西州锡考克斯 - Quest Diagnostics (NYSE:DGX) 周二宣布，其董事会已宣布季度现金股息为每股0.80美元，基于公司188.85美元的股价，当前收益率为1.74%。根据 InvestingPro 数据，Quest已连续22年保持股息支付，并连续14年提高股息。

Quest Diagnostics Inc. convinced a federal appeals court Thursday not to revive a class action that alleged the clinical laboratory improperly shared patients’ data with Meta Platforms Inc.

Net profit of Quest Laboratories declined 33.66% to Rs 4.02 crore in the quarter ended September 2025 as against Rs 6.06 crore during the pr ...

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an ...